Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer

Epigenetic silencing mediated by CpG methylation is a common feature of many cancers. Characterizing aberrant DNA methylation changes associated with tumor progression may identify potential prognostic markers for prostate cancer (PCa). We treated two PCa cell lines, 22Rv1 and DU-145 with the demeth...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: White-Al Habeeb, Nicole M. A., Ho, Linh T., Olkhov-Mitsel, Ekaterina, Kron, Ken, Pethe, Vaijayanti, Lehman, Melanie, Jovanovic, Lidija, Fleshner, Neil, van der Kwast, Theodorus, Nelson, Colleen C., Bapat, Bharati
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2014
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4202166/
https://ncbi.nlm.nih.gov/pubmed/25277202
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia